Pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic chemotherapy: A 7-year single-center experience

Tumori

Volumn 98, Issue 5, 2012, Pages 588-593

  Virzì, Salvatore ^a   Iusco, Domenico ^a   Bonomi, Serena ^a   Grassi, Antonio ^a  

^a Ospedale di Bentivoglio   (Italy)

Author keywords

Complete cytoreduction; Cytoreductive surgery; Peritonectomy; Pseudomyxoma peritonei

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN; OXALIPLATIN;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CARCINOMATOSIS; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; DISSEMINATED PERITONEAL ADENOMUCINOSIS; FEMALE; FOLLOW UP; HUMAN; HYPOTHERMIC INTRAPERITONEAL CHEMOTHERAPY; LIVER METASTASIS; MALE; MORBIDITY; OPERATION DURATION; OVERALL SURVIVAL; PERITONEAL CANCER INDEX; PERITONEAL MUCINOSIS CARCINOMATOSIS; PERITONECTOMY; PERITONEUM PSEUDOMYXOMA; RECURRENCE FREE SURVIVAL; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME;

EID: 84872068344     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/1190.13199     Document Type: Article

References (31)

1. Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA: Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol, 34: 196-201, 2008.
2. Fann JI, Vierra M, Fisher D, Oberhelman HA Jr, Cobb L: Pseudomyxoma peritonei. Surg Gynecol Obstet, 177: 441-447, 1993.
3. Moran BJ, Cecil TD: The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am, 12: 585-603, 2003.
4. Bevan KE, Mohamed F, Moran BJ: Pseudomyxoma peritonei. World J Gastrointest Oncol, 2: 44-50, 2010.
5. Deraco M, Baratti D, Inglese MG, Allaria B, Gavazzi C, Kusamura S: Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol, 11: 393-398, 2004.
6. Sugarbaker PH: Peritonectomy procedures. Ann Surg, 221: 29-42, 1995.
7. Brendan MJ, Cecil TD: The etiology, clinical presentation and management of pseudomyxoma peritonei. Surg Oncol Clin N Am, 12: 585-603, 2003.
8. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM: Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: a clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis and relationship to "pseudomyxoma peritonei". Am J Surg Pathol, 9: 1390-1408, 1995.
9. Szych C, Staebler A, Connolly DC, Wu R, Cho KR, Ronnett BM: Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women. Am J Pathol, 154: 1849-1855, 1999.
10. Carr NJ, Emory TS, Sobin LH: Epithelial neoplasms of the appendix and colorectum: an analysis of cell proliferation, apoptosis and expression of p53, CD44, bcl-2. Arch Pathol Lab Med, 126: 837-841, 2002.
11. Nonaka D, Kusamura S, Baratti D Casali P, Younan R, Deraco M: CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases. Histopathology, 49: 381-387, 2006.
12. Chejfec G, Rieker WJ, Jablokow VR, Gould VE: Pseudomyxoma peritonei associated with colloid carcinoma of the pancreas. Gastroenterology, 90: 202-205, 1986.
13. Yan TD, Sugarbaker PH, Brun EA: Pseudomyxoma peritonei from mucinous adenocarcinoma of the urachus. J Clin Oncol, 24: 4944-4946, 2006.
14. Hawes D, Robinson R, Wira R: Pseudomyxoma peritonei from metastatic colloid carcinoma of the breast. Gastrointest Radiol, 16: 80-82, 1991.
15. Ronnett BM, Seidman JD: Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei. Am J Surg Pathol, 27: 650-657, 2003.
16. Misdraji J, Yantiss RK, Graeme-Cook FM, Balis UJ, Young RH: Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol, 8: 1089-1103, 2003.
17. Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG: Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg, 241: 300-308, 2004.
18. Bryant J, Clegg AJ, Sidhu MK, Brodin H, Royle P, Davidson P: Clinical effectiveness and costs of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei. Health Technol Assess, 8: 1-54, 2004.
19. Yan TD, Black D, Savady R, Sugarbaker PH: A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol, 14: 484-492, 2007.
20. Smith JW, Kemeny N, Caldwell C, Banner P, Sigurdson E, Huvos A: Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience. Cancer, 70: 396-401, 1992.
21. Jess P, Iversen LH, Nielsen MB, Hansen F, Laurberg S, Rasmussen PC: Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study. Dis Colon Rectum, 51: 868-874, 2008.
22. Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA: Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg, 245: 104-109, 2007.
23. Guner Z, Schmidt U, Dahlke MH, Schlitt HJ, Klempnauer J, Piso P: Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis, 20: 155-160, 2005.
24. Van Leeuwen BL, Graf W, Pahlman L, Mahteme H: Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis. Ann Surg Oncol, 15: 745-753, 2008.
25. Vaira M, Cioppa T, DE Marco G, Bing C, D'Amico S, D'Alessandro M, Fiorentini G, DE Simone M: Management of pseudomyxoma peritonei by cytoreduction + HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience. In Vivo, 23: 639-644, 2009.
26. Moran B, Baratti D, Yan TD, Kusamura S, Deraco M: Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasm with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol, 98: 277-282, 2008.
27. McQuellon R, Gavazzi C, Piso P, Swain D, Levine E: Quality of life and nutritional assessment in peritoneal surface malignancy (PSM): recommendations for care. J Surg Oncol, 98: 300-305, 2008.
28. Sugarbaker PH, Alderman R, Edwards G, Marquardt CE, Gushchin V, Esquivel J, Chang D: Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol, 13: 615-644, 2006.
29. Kusamura S, Baratti D, Deraco M:Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies. Ann Surg, 255: 238-256, 2012.
30. Sugarbaker PH, Chang D: Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol, 6: 727-731, 1999.
31. Youssef H, Newman C, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ: Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin. Dis Colon Rectum, 54: 293-299, 2011.